Investors & Media

Event Details

Gemphire Announces Top-Line Data from INDIGO-1 Phase 2b Clinical Trial in Severe Hypertriglyceridemia Patients

06/28/18 at 4:30 PM EDT

Webcast Presentation

Supporting Materials